Peregrine Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Peregrine Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
October 30, 2007 at 12:00 AM EDT
- Presentation to Be Webcast Live on Company's Website -
TUSTIN, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus infection, today announced that senior management will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6, 2007 at 2:40 pm ET. The conference will be held at the New York Palace Hotel in New York City.
Peregrine CEO and president Steven W. King will provide a review of recent corporate developments.
Mr. King's presentation will be webcast live and can be accessed by visiting the Investor Relations section of Peregrine's website at http://www.peregrineinc.com. A replay will be available on the Peregrine website and archived for approximately 90 days.
For more information about this conference, please visit: http://www.rodmanandrenshaw.com/conferences?id=6
About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection in the U.S. and India with its lead product candidates bavituximab and Cotara®. Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.
Contacts: GendeLLindheim BioCom Partners Investors info@peregrineinc.com (800) 987-8256
Media Barbara Lindheim (212) 918-4650
SOURCE Peregrine Pharmaceuticals, Inc.
Web site: http://www.peregrineinc.com http://www.rodmanandrenshaw.com/conferences?id=6 http://www.avidbio.com
TUSTIN, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus infection, today announced that senior management will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6, 2007 at 2:40 pm ET. The conference will be held at the New York Palace Hotel in New York City.
Peregrine CEO and president Steven W. King will provide a review of recent corporate developments.
Mr. King's presentation will be webcast live and can be accessed by visiting the Investor Relations section of Peregrine's website at http://www.peregrineinc.com. A replay will be available on the Peregrine website and archived for approximately 90 days.
For more information about this conference, please visit: http://www.rodmanandrenshaw.com/conferences?id=6
About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection in the U.S. and India with its lead product candidates bavituximab and Cotara®. Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.
Contacts: GendeLLindheim BioCom Partners Investors info@peregrineinc.com (800) 987-8256
Media Barbara Lindheim (212) 918-4650
SOURCE Peregrine Pharmaceuticals, Inc.
Web site: http://www.peregrineinc.com http://www.rodmanandrenshaw.com/conferences?id=6 http://www.avidbio.com